Novavax Non Current Liabilities Total vs Intangible Assets Analysis

NVAX Stock

USD 4.09 0.14 3.54%

Novavax financial indicator trend analysis is infinitely more than just investigating Novavax recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Novavax is a good investment. Please check the relationship between Novavax Non Current Liabilities Total and its Intangible Assets accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Novavax. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in nation.

For more information on how to buy Novavax Stock please use our How to Invest in Novavax guide.

Non Current Liabilities Total vs Intangible Assets

Non Current Liabilities Total vs Intangible Assets Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Novavax Non Current Liabilities Total account and Intangible Assets. At this time, the significance of the direction appears to have strong contrarian relationship.

The correlation between Novavax's Non Current Liabilities Total and Intangible Assets is -0.55. Overlapping area represents the amount of variation of Non Current Liabilities Total that can explain the historical movement of Intangible Assets in the same time period over historical financial statements of Novavax, assuming nothing else is changed. The correlation between historical values of Novavax's Non Current Liabilities Total and Intangible Assets is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Non Current Liabilities Total of Novavax are associated (or correlated) with its Intangible Assets. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Intangible Assets has no effect on the direction of Non Current Liabilities Total i.e., Novavax's Non Current Liabilities Total and Intangible Assets go up and down completely randomly.

Correlation Coefficient

-0.55

Relationship Direction	Negative
Relationship Strength	Very Weak

View All Relationships

Non Current Liabilities Total

Intangible Assets

Non-physical assets possessed by a company, such as patents, trademarks, and copyrights, which provide long-term value.

Most indicators from Novavax's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Novavax current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Novavax. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in nation.

For more information on how to buy Novavax Stock please use our How to Invest in Novavax guide.At this time, Novavax's Selling General Administrative is fairly stable compared to the past year. Issuance Of Capital Stock is likely to rise to about 442.5 M in 2024, despite the fact that Tax Provision is likely to grow to (1.8 M).

Novavax fundamental ratios Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Common Stock Shares Outstanding	Other Current Assets	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Total Current Assets	Net Receivables	Non Current Liabilities Total	Intangible Assets	Short Long Term Debt Total	Common Stock Total Equity	Short Term Debt	Common Stock	Long Term Debt
Total Assets		0.78	0.94	-0.56	0.87	-0.87	-0.91	0.93	0.94	0.9	0.94	0.94	0.93	0.8	0.94	0.96	0.86	0.99	0.88	0.78	-0.46	0.71	-0.41	0.67	-0.37	0.33
Other Current Liab	0.78		0.9	-0.89	0.91	-0.66	-0.9	0.93	0.72	0.88	0.75	0.68	0.84	0.55	0.85	0.9	0.91	0.7	0.55	0.66	-0.35	0.53	-0.32	0.34	-0.26	0.02
Total Current Liabilities	0.94	0.9		-0.75	0.86	-0.88	-0.92	0.96	0.94	0.87	0.93	0.92	0.88	0.83	0.89	0.98	0.86	0.92	0.76	0.67	-0.4	0.68	-0.41	0.55	-0.36	0.21
Total Stockholder Equity	-0.56	-0.89	-0.75		-0.74	0.4	0.79	-0.72	-0.53	-0.71	-0.63	-0.45	-0.69	-0.4	-0.69	-0.76	-0.75	-0.48	-0.4	-0.62	0.35	-0.56	0.21	-0.06	0.15	-0.19
Property Plant And Equipment Net	0.87	0.91	0.86	-0.74		-0.62	-0.96	0.91	0.7	0.99	0.77	0.69	0.97	0.46	0.96	0.92	1.0	0.78	0.74	0.87	-0.43	0.56	-0.36	0.46	-0.3	0.14
Net Debt	-0.87	-0.66	-0.88	0.4	-0.62		0.67	-0.82	-0.94	-0.65	-0.87	-0.94	-0.67	-0.9	-0.68	-0.8	-0.61	-0.91	-0.74	-0.38	0.22	-0.45	0.47	-0.6	0.46	-0.03
Retained Earnings	-0.91	-0.9	-0.92	0.79	-0.96	0.67		-0.93	-0.8	-0.97	-0.86	-0.77	-0.98	-0.6	-0.99	-0.97	-0.96	-0.85	-0.77	-0.89	0.5	-0.72	0.34	-0.48	0.28	-0.33
Accounts Payable	0.93	0.93	0.96	-0.72	0.91	-0.82	-0.93		0.89	0.91	0.83	0.88	0.9	0.74	0.92	0.96	0.91	0.89	0.68	0.7	-0.41	0.67	-0.4	0.65	-0.36	0.17
Cash	0.94	0.72	0.94	-0.53	0.7	-0.94	-0.8	0.89		0.73	0.92	0.99	0.77	0.95	0.8	0.9	0.69	0.97	0.76	0.57	-0.4	0.73	-0.41	0.71	-0.39	0.34
Non Current Assets Total	0.9	0.88	0.87	-0.71	0.99	-0.65	-0.97	0.91	0.73		0.81	0.72	0.99	0.49	0.98	0.93	0.99	0.82	0.79	0.89	-0.44	0.59	-0.35	0.47	-0.29	0.19
Non Currrent Assets Other	0.94	0.75	0.93	-0.63	0.77	-0.87	-0.86	0.83	0.92	0.81		0.9	0.85	0.82	0.86	0.94	0.77	0.94	0.9	0.71	-0.43	0.66	-0.44	0.45	-0.41	0.35
Cash And Short Term Investments	0.94	0.68	0.92	-0.45	0.69	-0.94	-0.77	0.88	0.99	0.72	0.9		0.76	0.94	0.79	0.88	0.67	0.98	0.77	0.55	-0.41	0.7	-0.4	0.74	-0.38	0.32
Common Stock Shares Outstanding	0.93	0.84	0.88	-0.69	0.97	-0.67	-0.98	0.9	0.77	0.99	0.85	0.76		0.55	0.99	0.95	0.97	0.86	0.84	0.92	-0.48	0.65	-0.39	0.5	-0.34	0.29
Other Current Assets	0.8	0.55	0.83	-0.4	0.46	-0.9	-0.6	0.74	0.95	0.49	0.82	0.94	0.55		0.59	0.75	0.45	0.87	0.61	0.33	-0.32	0.68	-0.36	0.67	-0.36	0.34
Other Stockholder Equity	0.94	0.85	0.89	-0.69	0.96	-0.68	-0.99	0.92	0.8	0.98	0.86	0.79	0.99	0.59		0.96	0.96	0.87	0.82	0.91	-0.5	0.7	-0.34	0.54	-0.28	0.33
Total Liab	0.96	0.9	0.98	-0.76	0.92	-0.8	-0.97	0.96	0.9	0.93	0.94	0.88	0.95	0.75	0.96		0.92	0.92	0.82	0.81	-0.47	0.73	-0.39	0.54	-0.34	0.32
Property Plant And Equipment Gross	0.86	0.91	0.86	-0.75	1.0	-0.61	-0.96	0.91	0.69	0.99	0.77	0.67	0.97	0.45	0.96	0.92		0.77	0.73	0.87	-0.42	0.55	-0.36	0.43	-0.29	0.13
Total Current Assets	0.99	0.7	0.92	-0.48	0.78	-0.91	-0.85	0.89	0.97	0.82	0.94	0.98	0.86	0.87	0.87	0.92	0.77		0.87	0.7	-0.45	0.71	-0.41	0.72	-0.38	0.36
Net Receivables	0.88	0.55	0.76	-0.4	0.74	-0.74	-0.77	0.68	0.76	0.79	0.9	0.77	0.84	0.61	0.82	0.82	0.73	0.87		0.77	-0.38	0.49	-0.46	0.41	-0.43	0.31
Non Current Liabilities Total	0.78	0.66	0.67	-0.62	0.87	-0.38	-0.89	0.7	0.57	0.89	0.71	0.55	0.92	0.33	0.91	0.81	0.87	0.7	0.77		-0.55	0.7	-0.24	0.39	-0.18	0.52
Intangible Assets	-0.46	-0.35	-0.4	0.35	-0.43	0.22	0.5	-0.41	-0.4	-0.44	-0.43	-0.41	-0.48	-0.32	-0.5	-0.47	-0.42	-0.45	-0.38	-0.55		-0.59	0.11	-0.32	0.08	-0.53
Short Long Term Debt Total	0.71	0.53	0.68	-0.56	0.56	-0.45	-0.72	0.67	0.73	0.59	0.66	0.7	0.65	0.68	0.7	0.73	0.55	0.71	0.49	0.7	-0.59		-0.12	0.65	-0.1	0.82
Common Stock Total Equity	-0.41	-0.32	-0.41	0.21	-0.36	0.47	0.34	-0.4	-0.41	-0.35	-0.44	-0.4	-0.39	-0.36	-0.34	-0.39	-0.36	-0.41	-0.46	-0.24	0.11	-0.12		-0.34	0.99	0.09
Short Term Debt	0.67	0.34	0.55	-0.06	0.46	-0.6	-0.48	0.65	0.71	0.47	0.45	0.74	0.5	0.67	0.54	0.54	0.43	0.72	0.41	0.39	-0.32	0.65	-0.34		-0.34	0.37
Common Stock	-0.37	-0.26	-0.36	0.15	-0.3	0.46	0.28	-0.36	-0.39	-0.29	-0.41	-0.38	-0.34	-0.36	-0.28	-0.34	-0.29	-0.38	-0.43	-0.18	0.08	-0.1	0.99	-0.34		0.09
Long Term Debt	0.33	0.02	0.21	-0.19	0.14	-0.03	-0.33	0.17	0.34	0.19	0.35	0.32	0.29	0.34	0.33	0.32	0.13	0.36	0.31	0.52	-0.53	0.82	0.09	0.37	0.09

Click cells to compare fundamentals

Novavax Account Relationship Matchups

Novavax fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	173.0M	1.6B	2.6B	2.3B	1.9B	1.9B
Other Current Liab	19.9M	(327.6M)	709.8M	1.5B	1.2B	1.3B
Total Current Liabilities	25.8M	322.0M	2.4B	2.5B	1.6B	1.7B
Total Stockholder Equity	(186.0M)	627.2M	(351.7M)	(634.1M)	(716.9M)	(681.1M)
Property Plant And Equipment Net	11.4M	180.0M	228.7M	400.5M	491.0M	515.5M
Net Debt	243.1M	(231.4M)	(1.1B)	(787.1M)	(298.3M)	(283.4M)
Retained Earnings	(1.4B)	(1.9B)	(3.6B)	(4.3B)	(4.8B)	(4.6B)
Accounts Payable	2.9M	54.3M	127.1M	216.5M	132.6M	139.2M
Cash	78.8M	553.4M	1.5B	1.3B	578.9M	607.9M
Non Current Assets Total	75.7M	334.3M	421.6M	555.3M	711.5M	747.0M
Non Currrent Assets Other	7.5M	13.2M	56.7M	28.5M	30.3M	31.8M
Cash And Short Term Investments	78.8M	711.0M	1.5B	1.3B	578.9M	607.9M
Common Stock Shares Outstanding	24.1M	57.6M	74.4M	78.2M	100.8M	105.8M
Liabilities And Stockholders Equity	173.0M	1.6B	2.6B	2.3B	1.9B	1.9B
Other Current Assets	93.9M	441.8M	2.1B	1.7B	226.0M	191.7M
Other Stockholder Equity	1.3B	2.5B	3.3B	3.6B	4.1B	4.3B
Total Liab	359.0M	955.3M	2.9B	2.9B	2.6B	2.7B
Property Plant And Equipment Gross	11.4M	180.0M	258.6M	447.8M	566.0M	594.3M
Total Current Assets	97.2M	1.2B	2.2B	1.7B	1.1B	1.2B
Accumulated Other Comprehensive Income	(12.5M)	7.0M	(1.4M)	(6.4M)	2.7M	2.9M
Net Receivables	7.5M	262.0M	455.0M	82.4M	297.2M	312.1M
Non Current Liabilities Total	333.2M	633.2M	538.1M	432.8M	937.1M	984.0M
Intangible Assets	6.5M	5.6M	5.7M	4.8M	4.3M	4.1M
Short Long Term Debt Total	321.9M	322.0M	454.0M	549.8M	280.6M	294.7M
Common Stock Total Equity	3.8M	324K	714K	764K	878.6K	1.3M
Short Term Debt	1.3M	322.0M	130.5M	352.1M	28.1M	43.9M
Common Stock	324K	714K	764K	868K	1.4M	1.3M
Long Term Debt	320.6M	322.0M	323.5M	166.5M	168.0M	114.6M
Inventory	(83.0M)	(166.7M)	(2.0B)	36.7M	41.7M	43.8M
Property Plant Equipment	11.4M	180.0M	228.7M	400.5M	460.6M	483.6M
Other Liab	2.6M	3.4M	175.5M	185.0M	212.8M	223.4M
Current Deferred Revenue	1.7M	273.2M	1.4B	370.1M	241.3M	140.2M
Other Assets	1.1M	5.4M	16.6M	28.5M	32.7M	34.4M
Good Will	51.2M	135.4M	131.5M	126.3M	127.5M	133.8M
Net Tangible Assets	(242.8M)	486.1M	(487.9M)	(760.4M)	(684.4M)	(650.1M)
Retained Earnings Total Equity	(1.3B)	(1.4B)	(1.9B)	(3.6B)	(3.3B)	(3.1B)
Long Term Debt Total	319.2M	320.6M	322.0M	323.5M	372.0M	234.9M
Capital Surpluse	1.1B	1.3B	2.5B	3.4B	3.9B	4.0B

Novavax Investors Sentiment

The influence of Novavax's investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Novavax. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.

Investor biases related to Novavax's public news can be used to forecast risks associated with an investment in Novavax. The trend in average sentiment can be used to explain how an investor holding Novavax can time the market purely based on public headlines and social activities around Novavax. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.

Novavax's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Novavax's and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Novavax's news discussions. The higher the estimated score, the more favorable is the investor's outlook on Novavax.

Novavax Implied Volatility

85.87

Novavax's implied volatility exposes the market's sentiment of Novavax stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Novavax's implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Novavax stock will not fluctuate a lot when Novavax's options are near their expiration.

Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Novavax in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Novavax's short interest history, or implied volatility extrapolated from Novavax options trading.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect

When determining whether Novavax offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Novavax's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Novavax Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Novavax Stock:

How To Invest In Novavax

Details

Is Novavax Stock a good investment?

Details

What is Novavax's Net Worth?

Details

Largest Biotechnology Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Novavax. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in nation.

For more information on how to buy Novavax Stock please use our How to Invest in Novavax guide.

Note that the Novavax information on this page should be used as a complementary analysis to other Novavax's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.

Complementary Tools for Novavax Stock analysis

When running Novavax's price analysis, check to measure Novavax's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Novavax is operating at the current time. Most of Novavax's value examination focuses on studying past and present price action to predict the probability of Novavax's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Novavax's price. Additionally, you may evaluate how the addition of Novavax to your portfolios can decrease your overall portfolio volatility.

	Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
	Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios
	Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum
	Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
	Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
	Money Managers Screen money managers from public funds and ETFs managed around the world
	Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
	Global Correlations Find global opportunities by holding instruments from different markets
	Content Syndication Quickly integrate customizable finance content to your own investment portal

Is Novavax's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Novavax. If investors know Novavax will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Novavax listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(5.41)

Revenue Per Share

9.762

Quarterly Revenue Growth

(0.18)

Return On Assets

(0.17)

Return On Equity

(8.98)

The market value of Novavax is measured differently than its book value, which is the value of Novavax that is recorded on the company's balance sheet. Investors also form their own opinion of Novavax's value that differs from its market value or its book value, called intrinsic value, which is Novavax's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Novavax's market value can be influenced by many factors that don't directly affect Novavax's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Novavax's value and its price as these two are different measures arrived at by different means. Investors typically determine if Novavax is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Novavax's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Novavax Non Current Liabilities Total vs Intangible Assets Analysis

Non Current Liabilities Total vs Intangible Assets

Non Current Liabilities Total vs Intangible Assets Correlation Analysis

Correlation Coefficient

Non Current Liabilities Total

Intangible Assets

Novavax fundamental ratios Correlations

Novavax Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Novavax fundamental ratios Accounts

Novavax Investors Sentiment

Novavax Implied Volatility

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

Complementary Tools for Novavax Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Property Plant And Equipment Gross	+ 1.0	Property Plant And Equipment Net
Total Current Assets	+ 0.99	Total Assets
Non Current Assets Total	+ 0.99	Property Plant And Equipment Net
Cash And Short Term Investments	+ 0.99	Cash
Common Stock Shares Outstanding	+ 0.99	Non Current Assets Total
Property Plant And Equipment Gross	+ 0.99	Non Current Assets Total

Other Stockholder Equity	- 0.99	Retained Earnings
Common Stock Shares Outstanding	- 0.98	Retained Earnings
Total Liab	- 0.97	Retained Earnings
Non Current Assets Total	- 0.97	Retained Earnings
Property Plant And Equipment Gross	- 0.96	Retained Earnings
Retained Earnings	- 0.96	Property Plant And Equipment Net